On Monday 10th April 2017 at 8pm, We are extremely fortunate to have Janis Hickey, Director of the British Thyroid Foundation and Colin Dayan, Professor of Clinical Diabetes and Metabolism at Cardiff University School of Medicine, delivering another CPD masterclass on Thyroid disease.
This session will be looking at Hypothyroidism and Thyroid Hormone Replacement. Spontaneous hypothyroidism affects 1-2% of the UK population, especially women (5:1 F:M). The most common cause is autoimmune disease, and, less frequently, treatments used for hyperthyroidism and thyroid cancer: surgery and radioactive iodine. Congenital hypothyroidism affects one newborn in every 3,500-4000 births. Treatment has typically been considered to be simple, and yet there is expectation from a significant number of patients of a better quality of life than they currently experience.
Expected Learning Outcomes
- When should thyroid hormone be started and how; who can be “observed”
- What are the risks of under- or over-replacement
- Hypothyroidism in pregnancy, after treatment of thyroid cancer
- How to manage persistent symptoms
- When should alternative forms of thyroid hormone be considered
- When should patients be referred to an endocrinologist
This webinar is equivalent to 1 CPD credit
About our Speakers:
Janis Hickey, Director, British Thyroid Foundation
Janis Hickey was diagnosed with Graves’ disease and thyroid eye disease (TED) in 1984, a life-changing experience which, in 1991, led her to set up the British Thyroid Foundation (BTF), of which she is the director. Over a period of almost 20 years from 1989 Janis had seven rehabilitative operations – not always in the right order! – to correct the effects of TED.
Twenty years ago there was little information available for patients with thyroid disorders, and people with TED often felt isolated and didn’t know what to expect, but that has changed, thanks to the establishment of patient support groups such as the BTF www.btf-thyroid.org and the Thyroid Eye Disease Charitable Trust (TEDct) www.tedct.org.uk, and dedicated medical professionals, with whom both organisations work closely.
The TEAMeD campaign has brought together professionals and patients whose common goal is to improve treatment and care for people with thyroid eye disease.
Colin Dayan, MA MBBS, FRCP, PhD – Professor of Clinical Diabetes and Metabolism, Cardiff University School of Medicine
Colin Dayan trained in medicine at University College, Oxford, and Guy’s and Charing Cross Hospitals in London before obtaining a PhD in the immunology of Graves’ Disease in Laboratory of Marc Feldmann.
He then spent a year as an endocrine fellow at the Massachussetts General Hospital in Boston, USA before completing his specialist training in diabetes and endocrinology as a Lecturer in Bristol.
He became a consultant senior lecturer in medicine (diabetes/endocrinology) at the University of Bristol in 1995 and Head of Clinical Research at the Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology in Bristol in 2002.
In 2010, he was appointed to the Chair of Clinical Diabetes and Metabolism and Head of Section at Cardiff University School of Medicine.
His research interests in thyroid disease include thyroid autoimmunity, thyroid hormone replacement and bioavailability, genetic epidemiology as applied to population variation in thyroid hormone bioavailability and thyroid eye disease. He became secretary of the European Thyroid Association in 2013 and chairs the UK Thyroid Eye Disease Amsterdam Implementation Group.
How do I register?
The link to register will appear at the top of this page on the Friday before the date of the webinar. It will be in a green box called “tickets”. We are currently working on a way for you to be able to register for webinars further ahead.
Joining the webinar
When you register for this webinar you will be emailed a unique set of login details.
We hope you enjoy the webinar